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principles greatly facilitates integration, transformation and analysis of the data in a uniform format 
while keeping data in different layers according to their sources. The non-overlapping portions of the 
layers can be used to suggest new interactions, which might not have been detected by a particular type 
of experiment but highlighted in several others. 
 
The aim of our work is to develop a model capable of predicting missing information in PPI network of a 
given pathway from different available data of multiple types. To this end, it is necessary to start by 
assembling a Boolean model of the selected pathway using literature research findings. The core model 
will then be expanded by addition of new links to the network structure based on suggested 
connections from different layers of data. We will also devise a formal model by specifying the rules of 
PPI in order to filter validate whether the asserted interactions are viable. 
 
By applying this method, we will attempt to devise and complete the model for mitogen-activated 
protein kinase (MAPK) PPI network. MAPK network is a very well studied pathway and misregulated in 
various types of cancer. MAPK pathways are highly conserved pathways involve in regulation of various 
processes such as apoptosis, survival, growth, differentiation and migration in cell and disruption of 
each may lead to formation of tumor cell4. Their role in directing growth factor and mitogens is of 
particular interest in cancer studies. As such, our main focus will be on the role of critical elements 
involved in regulating these pathways. Our ultimate aim is to build a network structure based on 
available PPI knowledge and compare the network with the network built from experimental data in 
order to predict the missing information in the network topology. 
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The study of metabolic alterations in response to genetic and environmental perturbations has been a 
central topic in microbial metabolomics (Fiehn, 2002; Kol et al., 2010; Villas-Boas et al., 2008). Some of 
these alterations can be readily detected by changes in their surroundings, normally associated with 
metabolites that are released by cells as by-products of the metabolism or as extracellular signalling 
molecules to mediate cross-talk within microbial communities. The analysis of these metabolites, also 
known as metabolic footprinting, has been widely applied with different purposes: discriminating 
between metabolic phenotypes in order to classify and identify mutant strains (Villas-Boas et al., 2008); 
monitoring bioprocesses with the aim to detect specific metabolites that indicate alterations in the 
culture performance (Carneiro et al., 2011; Sue et al., 2011); and identifying quorum-sensing 
metabolites that indicate potential targets to annihilate pathogens (Birkenstock et al., 2012). These 
metabolic readouts have been also useful to give insights into intracellular metabolic activities and 
provide a straightforward way to analyse simultaneously multiple metabolic activities, since no 
extraction procedures are required to analyse the endometabolome (i.e., intracellular metabolites). 
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Thus, through metabolic footprint analysis we can assess central metabolic activities that characterize 
the reproduction and survival of organisms. 
 
We have developed a methodology to evaluate the metabolic state of microbial cultures by analysing 
the footprints of two microbial systems: the bacterium Escherichia coli and the human pathogen 
Helicobacter pylori  that increases the risk of gastric cancer. Strategies for sampling and sample 
preparation were developed, as well as the analytical procedures based on gas chromatography with 
mass spectrometry (GC-MS). A wide variety of metabolites was detected, including fatty, amino and 
organic acids, which allowed us to address changes in most central metabolic pathways, such as the 
tricarboxylic acid cycle (TCA cycle), the biosynthesis of amino and fatty acids, as well as other energy 
generating metabolic reactions.  
 
The analysis of extracellular metabolites of E. coli cultures at different growth conditions were first 
performed to discriminate the physiological state of cultures and to evaluate the metabolic alterations 
produced at different growth conditions. According to our results in these experiments, metabolic 
footprints are good indicators of alterations in the intracellular metabolism. Next, the metabolic 
footprints of H. pylori cultures were investigated to get insights on the catabolism of this human 
pathogen. Overall, fifteen amino acids were detected in extracellular medium; six of them were 
confirmed as essentials for H. pylori growth, four amino acids were identified as non-essentials and can 
be used as carbon source, whilst five amino acids were identified as non-essentials and non-carbon 
source. In addition, some organic acids were also identified as carbon sources for H. pylori. This 
metabolic footprint analysis of H. pylori cultures allowed us to uncover key metabolic activities, mainly 
related with amino acids catabolism and to get insight on the metabolic behaviour of this organism. 
 
The characterization of catabolic pathways, as well as of possible metabolic constraints, is of major 
importance to understand the dynamic basis of the interactions host–microbe in the human gut, and in 
particular to discover potential ‘diagnostic’ biomarkers. It is well-known that pathogen's metabolism can 
influence the host health and may affect drug metabolism, toxicity and the efficacy of therapies (Holmes 
et al., 2011). However, little is known about their metabolic structure and behaviour. Our methodology 
allows uncovering part of the metabolic structure of H. pylori metabolism and undisclosed catabolic 
activities.  
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Deregulations of signalling pathways are known to be involved in the emergence and progression of 
cancers. Reductionist approaches over the last few decades have provided us with good understanding 
of the main mechanistic steps in many pathways, which are traditionally viewed as cascades of events 
that translate a ligand-mediated extracellular signal into phenotypic outcomes. In reality, however, a 
ligand can trigger multiple pathways and multiple ligands can trigger overlapping pathways via feedback 
and crosstalk interactions which operate by means of transcriptional and non-transcriptional 
mechanisms. It is through these complex, integrated networks of signalling pathways that cells process 
and make fate-related decisions, rendering it difficult to dissect the contribution to phenotypic 
outcomes of different extracellular signals. 
 
To gain further understanding of how different signalling pathways exchange information to translate 
multiple extracellular signals into cellular phenotypes, we are developing a large-scale computational 
model which integrates many well-known signalling pathways, such as the MAPK/ERK pathway, 
PI3K/AKT pathway, JAK/STAT pathway, p53/Mdm2 pathway, and the Caspase signalling pathway. These 
pathways are triggered by a variety of stimuli such as the Epidermal Growth Factor (EGF), Cytokines, 
Insulin and Tumor Necrosis Factor (TNF), and lead to a wide range of phenotypic outcomes such as 
proliferation, differentiation, cell division, adhesion and apoptosis. 
 
Complex diseases such as cancers often result from multiple mutations, many of which occur in the 
pathways considered in our computational model.  Our large-scale model, therefore, has the potential 
to reveal how carcinogenic mutations modulate the signalling mechanisms and cause inappropriate 
cellular phenotypes which may lead to tumour development. This information can then be used to 
pinpoint parts of the signalling mechanisms that can be targeted for more efficient cancer therapy. The 
model would also be a valuable tool to explore novel therapies where combinations of different drugs 
are used to target multiple molecules.
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Background: The mammalian target of rapamycin (mTOR) signalling pathway plays central roles in the 
control of cell survival, proliferation and tumourogenesis. Recently, DEPTOR has been identified as a 
new mTOR-interacting protein whose degradation is mediated by both mTORC complexes (mTORC1/2). 
Their interplay endows the mTOR pathway with intricate interlinked feedback mechanisms capable of 
